wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34578584-4B8A07E6-7EA4-4AEE-AB00-311FC2326C59
Q34578584-4B8A07E6-7EA4-4AEE-AB00-311FC2326C59
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34578584-4B8A07E6-7EA4-4AEE-AB00-311FC2326C59
Phase I/II study of the Src inhibitor dasatinib in combination with erlotinib in advanced non-small-cell lung cancer.
P2860
Q34578584-4B8A07E6-7EA4-4AEE-AB00-311FC2326C59
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34578584-4B8A07E6-7EA4-4AEE-AB00-311FC2326C59
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f47e27190dc1deb7b882dfd865ae6bfc74fbe459
P2860
Metabolism and disposition of dasatinib after oral administration to humans.